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PROCEEDINGS
time pro vide comprehensive representative data on the 
knowledge and information needs of people with and 
without diabe tes in Germany.
A further focus will be on preparing the results specif-
ically for individual target groups. This will build on the 
tested and developing new health reporting formats [3].
Diabetes, largely the consequence of unhealthy life-
styles and living conditions, at the same time plays 
a significant role in the development of additional 
diseases. Consequently, the aim is to apply the consen-
sual indicators, data model, reporting formats and the 
accumulated expert knowledge to develop a PH surveil-
lance for chronic diseases.
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Over the past few decades, Germany has seen a signif-
icant increase in the number of people diagnosed with 
diabetes mellitus. Treating the disease and the related 
long-term complications is now a central field of public 
health (PH) action. To meet this challenge, and taking 
diabetes as an example, the Robert Koch Institute (RKI) 
initiated a surveillance project in 2015. Accompanied 
by national and international experts and stakeholders 
of health reporting (GBE) at the federal state level, the 
project’s running time was set at four years [1].
Generally speaking, PH surveillance consists of con-
tinuously and systematically analysing health data from 
multiple sources to provide a rapid response in the form 
of health promoting measures [2]. 
The first step therefore consisted in developing ade-
quate indicators. Based on a multitier Delphi procedure, 
these indicators were condensed to a set of core and addi-
tional indicators. In addition to epidemiologic parame-
ters, these also contain indicators for risk factors and 
health care provision.
The data model to represent indicators is based both 
on RKI health monitoring data as well as on secondary 
data. The contributions presented in these proceedings 
on the current Health in Germany survey and the poten-
tial of Data Transparency Regulations highlights the 
potential for analysis in both data types.
Moreover, a telephone survey conducted by the RKI in 
2017 as part of the diabetes surveillance will for the first 
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